GLOBAL SOLUTIONS FOR INFECTIOUS DISEASES (EIN 200941177) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2004

Legal Domicile

Principal Officer

CARTER A LEE

Phone

6502287908

Tax Period

2024-01-01 to 2024-12-31

GLOBAL SOLUTIONS FOR INFECTIOUS DISEASES, founded in 2004, is a micro nonprofit that reported $17K in total revenue in fiscal year 2024. Revenue fell 98% from the prior year — a significant decline worth monitoring. Expenses of $345K exceeded revenue, resulting in a 1959% operating deficit.

Mission

THE MISSION OF GSID IS TO EXPAND THE DEVELOPMENT OF LOW-COST EFFECTIVE TOOLS FOR THE DIAGNOSIS AND PREVENTION OF INFECTIOUS DISEASES AFFLICTING LESS DEVELOPED COUNTRIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $16,765

Other Revenue $0

TOTAL REVENUE $16,765

Expense Breakdown

Grants Paid $0

Salaries & Benefits $303,077

Fundraising Expenses $30,308

Program Expenses $263,889

Other Expenses $42,069

TOTAL EXPENSES $345,146

Year-over-Year Comparison

	2024	2023	Change
Revenue	$16,765	$809,948	-1.0%
Expenses	$345,146	$797,034	-0.6%
Net Income	$-328,381	$12,914	-26.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$203,000

Total Directors

$223,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CARTER A LEE	EXECUTIVE DIRECTOR	20.00	Officer Director	$203,000	$0	$203,000
FARUK M SINANGIL	BOARD MEMBER/DIRECTOR RESEARCH COLLABORATIONS	1.00	Director	$0	$0	$0
DR SEUNG-IL SHIN	BOARD MEMBER	1.00	Director	$20,000	$0	$20,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$16,765	$345,146	$206,881	$-328,381
2023	$809,948	$797,034	$539,017	$12,914
2022	$961,683	$1,042,834	$528,108	$-81,151
2021	$1,338,688	$1,059,111	$609,139	$279,577
2020	$1,128,778	$1,038,942	$351,151	$89,836
2019	$926,380	$1,079,532	$252,856	$-153,152
2018	$1,439,966	$1,517,133	$407,572	$-77,167

GLOBAL SOLUTIONS FOR INFECTIOUS DISEASES